{
    "code": "01020385",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01020385",
    "time": "2023-09-14 23:07:52",
    "許可證字號": "衛署藥製字第020385號",
    "註銷狀態": "已註銷",
    "註銷日期": "112\/07\/03",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "108\/05\/25",
    "發證\/登錄日期": "69\/02\/02",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102038508",
    "中文品名": "&quot;華盛頓&quot;吉膚黴素膠囊250毫克（灰黴素）",
    "英文品名": "GFMYCIN CAPSULE 250MG (GRISEOFULVIN) &quot;WST&quot;",
    "適應症": "甲癬 (Onychomyosis)、 髮癬 (Tinea Capitis)，不適宜局部外用治療或局部外用無效的皮膚黴菌感染",
    "劑型": "130膠囊劑",
    "包裝": "100、500、1000 顆瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GRISEOFULVIN",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "華盛頓製藥廠股份有限公司",
    "申請商地址": "高雄市仁武區仁武里工業二路12號",
    "主製造廠": [
        {
            "製造廠名稱": "華盛頓製藥廠股份有限公司",
            "製造廠廠址": "高雄市仁武區仁武里工業二路12號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30042000211 人用醫藥製劑，含抗黴菌劑類抗生素者Medicaments, containing antifungal antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812200500",
            "成分名稱": "GRISEOFULVIN",
            "含量描述": "(POTENCY) 250",
            "含量": "",
            "單位": "MG"
        }
    ]
}